FastForward Innovations earns 7,5 million from the sale of EMMAC and hires Alfredo Pascual

A FastForward Innovations gained EUR 7,5 million (£6,5 million) in cash to invest after completing the sale of EMAC LifeSciences to Curaleaf Holdings Inc. and appointed Alfredo Pascual as Vice-President of Investment Analysis as of April 1, 2021. It is recalled that Ângelo Correia also raised more than 10 million euros with the same transaction from EMMAC to Curaleaf.

The main objective of FastForward Innovations Ltd (listed on the London Stock Exchange as LON: FFWD) is to invest in the medical cannabis, cannabinoid wellness and life sciences sectors.

Alfredo Pascual is a well-known name in global markets, having worked in the cannabis field since late 2016, namely as an analyst at MJBizDaily. Alfredo will now focus on evaluating investment opportunities in the burgeoning European medical cannabis industry, as well as supporting the growth of FastForward's portfolio companies in the sector.

Alfredo worked as an International Analyst at Marijuana Business Daily (MJBizDaily), which is dedicated to disseminating US-based business news and information, focusing on how cannabis markets and investments were evolving internationally.

“This is an important time to join the FastForward team and I look forward to aligning my experience in the burgeoning European medical cannabis sector with its position in the UK as the only listed investment fund with significant exposure in this space. After spending the last few years analyzing the complex European cannabis industry, I am excited to now work with FastForward to find and evaluate companies that are well positioned to capitalize on the opportunities presented in the sector and that are potential investment opportunities for FastForward. ”, said in a statement Alfredo Pascual, who collaborated with Cannareporter on publication of some Articles.

FastForward Innovations has confirmed that it has received £5,04 million from the sale of its entire stake in EMMAC Life Sciences to Curaleaf Holdings Inc. The company owned 6.666.667 shares of common stock and a £750 convertible loan note.

“We are pleased to note that all conditions in the sale of EMMAC to Curaleaf have been met and the transaction has been completed,” said Ian Burns, president of FastForward Innovations, in a statement. “We are delighted to have achieved a significant return on our original investment in EMMAC. This results in us being in an enviable position to have cash, totaling over £6,5m, which we intend to invest in exciting new opportunities, particularly in the highly active medical cannabis, cannabinoid wellness and life science sectors.” .